C1GALT1基因单核苷酸多态性与IgAV易感性的相关性研究
Study on the Correlation between Single Nucleotide Polymorphisms of C1GALT1 Gene and Susceptibility to Immunoglobulin A Vasculitis (IgAV)
DOI: 10.12677/acm.2026.1631021, PDF,   
作者: 苑富豪:青岛大学青岛医学院,山东 青岛;青岛大学附属医院儿童肾脏风湿免疫科,山东 青岛;咸雨蔚:青岛市市立医院超声诊断科,山东 青岛;王大海, 柏 翠, 林 毅*:青岛大学附属医院儿童肾脏风湿免疫科,山东 青岛
关键词: 核心1β13-半乳糖基转移酶IgA血管炎基因多态性儿童Core 1β13-Galactosyltransferase IgA Vasculitis Gene Polymorphism Children
摘要: 目的:研究核心1β1,3半乳糖基转移酶(C1GALT1)基因4个单核苷酸多态性位点(rs13226913、rs7790522、rs1047763、rs5882115)与IgA血管炎(IgAV)及IgA血管炎肾炎(IgAVN)的相关性。方法:本项课题共选取IgA血管炎(IgAV)患病儿童156例设为病例组;依据患儿是否伴随肾脏损害情况,将IgAV患病儿童划分为紫癜性肾炎(IgAVN)组、非紫癜性肾炎(NIgAVN)组;按照患儿是否存在腹痛、关节痛表现,分成有腹痛症状组、无腹痛症状组,有关节疼痛症状组、无关节疼痛症状组;根据IgAVN患病儿童是否出现蛋白尿现象,将其分为伴蛋白尿组与无蛋白尿组。此外选取152例健康儿童作为正常参照组。采用iMLDRTM多重SNP分型技术对C1GALT1基因的4个单核苷酸多态性位点(rs13226913、rs7790522、rs1047763、rs5882115)进行基因分型,分析各SNP与IgAV易感性及各临床表型之间的相关性。结果:C1GALT1基因中rs5882115中TC等位基因在蛋白尿组(44%)中的分布频率高于无蛋白尿组(13%),差异具有统计学意义(P < 0.05),C1GALT1基因上述4个位点的等位基因分布频次,在病例组与对照组之间的差异未达统计学显著水平(P > 0.05);对上述四个单核苷酸多态性位点进行连锁不平衡及单倍型分析,发现其中rs5882115、rs7790522、rs1047763等位基因组成的TCGG单倍型在蛋白尿组分布频率大于无蛋白尿组,具有统计学意义(P < 0.05)。结论:rs5882115中TC等位基因可能是IgAVN儿童出现蛋白尿的易感等位基因,而与儿童IgAV易感性无相关性;IgAVN患儿在TCGG单倍型的遗传背景下出现蛋白尿的风险更高;未发现C1GALT1基因rs13226913、rs7790522、rs1047763位点单核苷酸多态性与IgAV易感性及其临床表现的相关性。
Abstract: Objective: This study aims to explore the potential relationship between four specific single nucleotide polymorphisms (SNPs) located at rs13226913, rs7790522, and two other SNPs (rs7843021 and rs1000130) and their impact on immunoglobulin A vasculitis (IgAV) as well as IgA vasculitis nephritis (IgAVN). Methods: A total of 156 children with IgAV were enrolled as the case group. Based on the presence or absence of renal injury, these children were divided into the purpura nephritis (IgAVN) group and the non-purpura nephritis (NIgAVN) group. They were further divided into abdominal pain group, non-abdominal pain group, joint pain group, and non-joint pain group according to the presence or absence of abdominal pain and joint pain symptoms. In addition, children with IgAVN were divided into the proteinuria group and the non-proteinuria group based on the presence or absence of proteinuria. Meanwhile, 152 healthy children were selected as the normal control group. The iMLDRTM multiplex SNP genotyping technology was used to genotype the four SNP loci (rs13226913, rs7790522, rs1047763, rs5882115) of the C1GALT1 gene, and the association between each SNP and the susceptibility to IgAV as well as various clinical phenotypes was analyzed. Results: The frequency of the TC allele at rs5882115 of the C1GALT1 gene was higher in the proteinuria group (44%) than in the non-proteinuria group (13%), with a statistically significant difference (P < 0.05). There was no statistically significant difference in the allele distribution frequency at these four loci of the C1GALT1 gene between the case group and the control group (P > 0.05). Linkage disequilibrium and haplotype analysis of the above four SNP loci showed that the frequency of the TCGG haplotype (composed of alleles of rs5882115, rs7790522, and rs1047763) in the proteinuria group was higher than that in the non-proteinuria group, with statistical significance (P < 0.05). Conclusion: The TC allele at rs5882115 may be a susceptible allele for proteinuria in children with IgAVN, but it is not associated with the susceptibility to IgAV in children. Children with IgAVN have a higher risk of developing proteinuria in the genetic background of the TCGG haplotype. No association was found between the SNPs at rs13226913, rs7790522, and rs1047763 loci of the C1GALT1 gene and the susceptibility to IgAV and its clinical manifestations.
文章引用:苑富豪, 咸雨蔚, 王大海, 柏翠, 林毅. C1GALT1基因单核苷酸多态性与IgAV易感性的相关性研究[J]. 临床医学进展, 2026, 16(3): 2265-2274. https://doi.org/10.12677/acm.2026.1631021

参考文献

[1] 中华医学会儿科学分会免疫学组, 中华儿科杂志编辑委员会, 中国儿童风湿免疫病联盟, 等. 中国儿童IgA血管炎诊断与治疗指南(2023) [J]. 中华儿科杂志, 2023, 61(12): 1067-1076.
[2] Shi, D., Chan, H., Yang, X., Zhang, G., Yang, H., Wang, M., et al. (2019) Risk Factors Associated with Iga Vasculitis with Nephritis (Henoch-Schönlein Purpura Nephritis) Progressing to Unfavorable Outcomes: A Meta-Analysis. PLOS ONE, 14, e0223218. [Google Scholar] [CrossRef] [PubMed]
[3] Pillebout, E. and Sunderkötter, C. (2021) IgA Vasculitis. Seminars in Immunopathology, 43, 729-738. [Google Scholar] [CrossRef] [PubMed]
[4] Yu, H.H., Chu, K.H., Yang, Y.H., Lee, J., Wang, L., Lin, Y., et al. (2010) Genetics and Immunopathogenesis of IgA Nephropathy. Clinical Reviews in Allergy & Immunology, 41, 198-213. [Google Scholar] [CrossRef] [PubMed]
[5] Suzuki, H., Yasutake, J., Makita, Y., Tanbo, Y., Yamasaki, K., Sofue, T., et al. (2018) IgA Nephropathy and Iga Vasculitis with Nephritis Have a Shared Feature Involving Galactose-Deficient IgA1-Oriented Pathogenesis. Kidney International, 93, 700-705. [Google Scholar] [CrossRef] [PubMed]
[6] Pirulli, D., Crovella, S., Ulivi, S., Zadro, C., Bertok, S., Rendine, S., et al. (2009) Genetic Variant of c1galt1 Contributes to the Susceptibility to IgA Nephropathy. Journal of Nephrology, 22, 152-159. [Google Scholar] [CrossRef
[7] 黄松明. 紫癜性肾炎诊治循证指南(2016) [J]. 中华儿科杂志, 2017, 55(9): 647-651.
[8] 2012 International Society of Nephrology (2012) Henoch-Schönlein Purpura Nephritis. Kidney International Supplements, 2, 218-220.
[9] Hastings, M.C., Rizk, D.V., Kiryluk, K., Nelson, R., Zahr, R.S., Novak, J., et al. (2021) IgA Vasculitis with Nephritis: Update of Pathogenesis with Clinical Implications. Pediatric Nephrology, 37, 719-733. [Google Scholar] [CrossRef] [PubMed]
[10] Pirillo, A., Svecla, M., Catapano, A.L., Holleboom, A.G. and Norata, G.D. (2020) Impact of Protein Glycosylation on Lipoprotein Metabolism and Atherosclerosis. Cardiovascular Research, 117, 1033-1045. [Google Scholar] [CrossRef] [PubMed]
[11] Eichler, J. (2019) Protein Glycosylation. Current Biology, 29, R229-R231. [Google Scholar] [CrossRef] [PubMed]
[12] Hiki, Y., Tanaka, A., Kokubo, T., Iwase, H., Nishikido, J., Hotta, K., et al. (1998) Analyses of IgA1 Hinge Glycopeptides in IgA Nephropathy by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry. Journal of the American Society of Nephrology, 9, 577-582. [Google Scholar] [CrossRef] [PubMed]
[13] Tomana, M., Novak, J., Julian, B.A., Matousovic, K., Konecny, K. and Mestecky, J. (1999) Circulating Immune Complexes in IgA Nephropathy Consist of IgA1 with Galactose-Deficient Hinge Region and Antiglycan Antibodies. Journal of Clinical Investigation, 104, 73-81. [Google Scholar] [CrossRef] [PubMed]
[14] Lau, K.K., Suzuki, H., Novak, J. and Wyatt, R.J. (2010) Pathogenesis of Henoch-Schönlein Purpura Nephritis. Pediatric Nephrology, 25, 19-26. [Google Scholar] [CrossRef] [PubMed]
[15] Song, Y., Huang, X., Yu, G., Qiao, J., Cheng, J., Wu, J., et al. (2021) Pathogenesis of IgA Vasculitis: An Up-to-Date Review. Frontiers in Immunology, 12, Article ID: 771619. [Google Scholar] [CrossRef] [PubMed]
[16] Ju, T., Brewer, K., D'Souza, A., Cummings, R.D. and Canfield, W.M. (2002) Cloning and Expression of Human Core 1 β1,3-Galactosyltransferase. Journal of Biological Chemistry, 277, 178-186. [Google Scholar] [CrossRef] [PubMed]
[17] González-Ramírez, A.M., Grosso, A.S., Yang, Z., Compañón, I., Coelho, H., Narimatsu, Y., et al. (2022) Structural Basis for the Synthesis of the Core 1 Structure by C1galt1. Nature Communications, 13, Article No. 2398. [Google Scholar] [CrossRef] [PubMed]
[18] Hang, H.C. and Bertozzi, C.R. (2005) The Chemistry and Biology of Mucin-Type O-Linked Glycosylation. Bioorganic & Medicinal Chemistry, 13, 5021-5034. [Google Scholar] [CrossRef] [PubMed]
[19] Sun, X., Zhan, M., Sun, X., Liu, W. and Meng, X. (2021) C1GALT1 in Health and Disease (Review). Oncology Letters, 22, Article No. 589. [Google Scholar] [CrossRef] [PubMed]
[20] Li, G., Zhang, H., Lv, J., Shen, Y. and Wang, H. (2007) Variants of C1GALT1 Gene Are Associated with the Genetic Susceptibility to IgA Nephropathy. Kidney International, 71, 448-453. [Google Scholar] [CrossRef] [PubMed]
[21] Kiryluk, K., Li, Y., Moldoveanu, Z., Suzuki, H., Reily, C., Hou, P., et al. (2017) GWAS for Serum Galactose-Deficient IgA1 Implicates Critical Genes of the O-Glycosylation Pathway. PLOS Genetics, 13, e1006609. [Google Scholar] [CrossRef] [PubMed]
[22] Gu, Y., Zhang, Y., Zheng, Z. and Zhu, P. (2024) Clinical Characteristics and Risk Factors Analysis of Abdominal Symptoms in IgA Vasculitis Patients: A Retrospective Cohort Study. Clinical Rheumatology, 44, 349-356. [Google Scholar] [CrossRef] [PubMed]
[23] Reich, H.N., Troyanov, S.A.A., Scholey, J.W. and Cattran, D.C. (2007) Remission of Proteinuria Improves Prognosis in IgA Nephropathy. Journal of the American Society of Nephrology, 18, 3177-3183. [Google Scholar] [CrossRef] [PubMed]
[24] Haberle, V. and Stark, A. (2018) Eukaryotic Core Promoters and the Functional Basis of Transcription Initiation. Nature Reviews Molecular Cell Biology, 19, 621-637. [Google Scholar] [CrossRef] [PubMed]
[25] Kamei, K., Harada, R., Hamada, R., Sakai, T., Hamasaki, Y., Hataya, H., et al. (2016) Proteinuria during Follow-Up Period and Long-Term Renal Survival of Childhood IgA Nephropathy. PLOS ONE, 11, e0150885. [Google Scholar] [CrossRef] [PubMed]
[26] Wakaki, H., Ishikura, K., Hataya, H., Hamasaki, Y., Sakai, T., Yata, N., et al. (2011) Henoch-Schönlein Purpura Nephritis with Nephrotic State in Children: Predictors of Poor Outcomes. Pediatric Nephrology, 26, 921-925. [Google Scholar] [CrossRef] [PubMed]